156 related articles for article (PubMed ID: 26869000)
41. A review of breast cancer chemoprevention.
Chang JC
Biomed Pharmacother; 1998; 52(3):133-6. PubMed ID: 9755806
[TBL] [Abstract][Full Text] [Related]
42. Another view of tamoxifen.
Napoli M
Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681
[No Abstract] [Full Text] [Related]
43. Continuation of the International Breast Cancer Intervention Study (IBIS).
Cuzick J
Eur J Cancer; 1998 Oct; 34(11):1647-8. PubMed ID: 9893646
[No Abstract] [Full Text] [Related]
44. Breast cancer genetics and the role of tamoxifen in prevention.
Cain S
J Am Acad Nurse Pract; 2000 Jan; 12(1):21-8; quiz 29-31. PubMed ID: 11033680
[No Abstract] [Full Text] [Related]
45. Clear thinking on tamoxifen.
Johns Hopkins Med Lett Health After 50; 1998 Jul; 10(5):1-2. PubMed ID: 9650523
[No Abstract] [Full Text] [Related]
46. Tamoxifen for the prevention of breast cancer in high-risk women.
Sweeney FW; Newton WP
J Fam Pract; 1999 Feb; 48(2):90-1. PubMed ID: 10037532
[No Abstract] [Full Text] [Related]
47. Drop-outs in tamoxifen prevention trials.
Veronesi U; Maisonneuve P; Costa A; Rotmensz N; Boyle P
Lancet; 1999 Jan; 353(9148):244. PubMed ID: 9923912
[No Abstract] [Full Text] [Related]
48. Drop-outs in tamoxifen prevention trials.
Cuzick J; Edwards R
Lancet; 1999 Mar; 353(9156):930. PubMed ID: 10094016
[No Abstract] [Full Text] [Related]
49. Tamoxifen and beyond.
Harv Womens Health Watch; 1998 Jun; 5(10):1. PubMed ID: 9663008
[No Abstract] [Full Text] [Related]
50. Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen?
Bergh J
Lancet; 2003 Jul; 362(9379):183-4. PubMed ID: 12885476
[No Abstract] [Full Text] [Related]
51. Tamoxifen's effect in women with breast cancer.
Bryson A; Massey J
Lancet; 2001 Apr; 357(9264):1291; author reply 1291-2. PubMed ID: 11421213
[No Abstract] [Full Text] [Related]
52. Tamoxifen's effect in women with breast cancer.
Eisinger F; Julian-Reynier C; Sobol H
Lancet; 2001 Apr; 357(9264):1291-2. PubMed ID: 11421212
[No Abstract] [Full Text] [Related]
53. Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatment.
Veronesi A; Pizzichetta MA; Ferlante MA; Zottar M; Magri MD; Crivellari D; Foladore S
Tumori; 1998; 84(3):372-5. PubMed ID: 9678620
[TBL] [Abstract][Full Text] [Related]
54. Tamoxifen, raloxifene, and the prevention of breast cancer.
Jordan VC; Morrow M
Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
[No Abstract] [Full Text] [Related]
55. [Prevention of breast cancer using tamoxifen].
Foidart JM; Colin C; Lifrange E
Rev Med Liege; 1998 Apr; 53(4):225-6. PubMed ID: 9641022
[No Abstract] [Full Text] [Related]
56. Tamoxifen chemoprevention: public health goals, toxicities for all and benefits to a few.
Love RR
Ann Oncol; 1995 Feb; 6(2):127-8. PubMed ID: 7786819
[No Abstract] [Full Text] [Related]
57. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Love RR
J Natl Cancer Inst; 1999 Nov; 91(21):1891-2. PubMed ID: 10547398
[No Abstract] [Full Text] [Related]
58. Breast cancer: risk, prevention, & tamoxifen.
Machia J
Am J Nurs; 2001 Apr; 101(4):26-35; quiz 36. PubMed ID: 11301680
[No Abstract] [Full Text] [Related]
59. Chemoprevention of breast cancer.
Cuzick J
Breast Cancer; 2008; 15(1):10-6. PubMed ID: 18224388
[TBL] [Abstract][Full Text] [Related]
60. Chemoprevention of breast cancer.
O'Shaughnessy JA
JAMA; 1996 May; 275(17):1349-53. PubMed ID: 8614122
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
